Leki przeciwnowotworowe i immunomodulujące
Liczba leków: 2026
Revlimid25 mg
Bristol-Myers Squibb Pharma EEIGLENALIDOMIDUM 25 MG
Revlimid7,5 mg
Bristol-Myers Squibb Pharma EEIGLENALIDOMIDUM 7.5 MG
Revlimid2,5 mg
Bristol-Myers Squibb Pharma EEIGLENALIDOMIDUM 25 MG
Revlimid5 mg
Bristol-Myers Squibb Pharma EEIGLENALIDOMIDUM 5 MG
Rinvoq15 mg
AbbVie Deutschland GmbH & Co. KGUPADACITINIBUM 15 MG
Rinvoq30 mg
AbbVie Deutschland GmbH & Co. KGUPADACITINIBUM 30 MG
Rinvoq45 mg
AbbVie Deutschland GmbH & Co. KGUPADACITINIBUM 45 MG
Riulvy348 mg
Neuraxpharm Pharmaceuticals, S.L.TEGOMIL FUMARATE/348 MG
Riulvy174 mg
Neuraxpharm Pharmaceuticals, S.L.TEGOMIL FUMARATE/174 MG
Rixathon10 mg/ml (500 mg)
Sandoz GmbHRITUXIMABUM 500 MG
Riximyo10 mg/ml (500 mg)
Sandoz GmbHRITUXIMABUM 500 MG
Riximyo10 mg/ml (100 mg)
Sandoz GmbHRITUXIMABUM 100 MG
RoActemra20 mg/ml
Roche Registration GmbHTOCILIZUMABUM 20 MG/ML
RoActemra162 mg
Roche Registration GmbHTOCILIZUMABUM 162 MG/0.9 ML
Romvimza20 mg
Deciphera Pharmaceuticals (Netherlands) B.V.VIMSELTINIB 20 MG
Romvimza30 mg
Deciphera Pharmaceuticals (Netherlands) B.V.VIMSELTINIB 30 MG
Romvimza14 mg
Deciphera Pharmaceuticals (Netherlands) B.V.VIMSELTINIB 14 MG
Rozlytrek50 mg
Roche Registration GmbHENTRECTINIBUM 50 MG
Rozlytrek200 mg
Roche Registration GmbHENTRECTINIBUM 200 MG
Rozlytrek100 mg
Roche Registration GmbHENTRECTINIBUM 100 MG
Rubraca200 mg
pharmaand GmbHRUCAPARIBUM 200 MG
Rubraca300 mg
pharmaand GmbHRUCAPARIBUM 300 MG
Rubraca250 mg
pharmaand GmbHRUCAPARIBUM 250 MG
Ruxience500 mg
Pfizer Europe MA EEIGRITUXIMABUM 500 MG